These modified ASOs had higher inhibition efficacies than conventional hairpins, and the antisense molecules decreased the proliferation of LC cell line expressing mutant KRAS (G12C) gene [209]. The gene discussed is KRAS; the disease is laryngotracheoesophageal cleft.